CCP
ELV icon

Carmel Capital Partners’s Elevance Health ELV Stock Holding History

Carmel Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$8.71K – 305
2023
Q3 		$8.71K Buy
20
+1
+5% +$454 ﹤0.01% 477
2023
Q2 		$8.44K Sell
19
-183
-91% -$84.4K ﹤0.01% 295
2023
Q1 		$92.9K Buy
+202
New +$96.1K 0.05% 195

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmel Capital Partners's ELV Position: Q4 2023 in Review

Carmel Capital Partners sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 20 shares — an estimated $8.71K sold.

Carmel Capital Partners first reported a position in ELV in Q1 2023 and held it in 3 quarters. The position peaked at $92.9K in Q1 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Carmel Capital Partners reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 20 Elevance Health shares in Q4 2023, an estimated $8.71K.
  • Carmel Capital Partners first reported a position in Elevance Health in Q1 2023 and held it in 3 quarters.
  • Carmel Capital Partners's Elevance Health position peaked at $92.9K in Q1 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.